- Home
- IVP vs SHPH Comparison
IVP vs SHPH Comparison
Compare IVP & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- SHPH
- Stock Information
- Founded
- IVP 2020
- SHPH 2012
- Country
- IVP United States
- SHPH United States
- Employees
- IVP N/A
- SHPH N/A
- Industry
- IVP Diversified Commercial Services
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- IVP Miscellaneous
- SHPH Health Care
- Exchange
- IVP Nasdaq
- SHPH Nasdaq
- Market Cap
- IVP 3.5M
- SHPH 3.2M
- IPO Year
- IVP 2023
- SHPH 2022
- Fundamental
- Price
- IVP $0.77
- SHPH $2.33
- Analyst Decision
- IVP
- SHPH
- Analyst Count
- IVP 0
- SHPH 0
- Target Price
- IVP N/A
- SHPH N/A
- AVG Volume (30 Days)
- IVP 107.1K
- SHPH 355.7K
- Earning Date
- IVP 11-12-2025
- SHPH 11-13-2025
- Dividend Yield
- IVP N/A
- SHPH N/A
- EPS Growth
- IVP N/A
- SHPH N/A
- EPS
- IVP N/A
- SHPH N/A
- Revenue
- IVP $15,292,904.00
- SHPH N/A
- Revenue This Year
- IVP N/A
- SHPH N/A
- Revenue Next Year
- IVP N/A
- SHPH N/A
- P/E Ratio
- IVP N/A
- SHPH N/A
- Revenue Growth
- IVP N/A
- SHPH N/A
- 52 Week Low
- IVP $0.63
- SHPH $2.22
- 52 Week High
- IVP $6.38
- SHPH $27.70
- Technical
- Relative Strength Index (RSI)
- IVP 41.66
- SHPH 29.95
- Support Level
- IVP $0.67
- SHPH $2.25
- Resistance Level
- IVP $0.85
- SHPH $2.63
- Average True Range (ATR)
- IVP 0.05
- SHPH 0.24
- MACD
- IVP -0.01
- SHPH -0.04
- Stochastic Oscillator
- IVP 46.90
- SHPH 8.21
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.